![JCM | Free Full-Text | Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease JCM | Free Full-Text | Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease](https://pub.mdpi-res.com/jcm/jcm-09-01639/article_deploy/html/images/jcm-09-01639-ag-550.jpg?1592806940)
JCM | Free Full-Text | Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease
![Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials - The Lancet Respiratory Medicine Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/d3bb598d-90e3-4c9b-bd9a-c8296c8f2702/gr1_lrg.gif)
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials - The Lancet Respiratory Medicine
![Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ | ACS Omega Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.8b03428/asset/images/large/ao-2018-03428g_0006.jpeg)